Neudle.com: JC virus antibodies

Differential
(Click to cross reference)

abscess, intracerebral

abulia

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome, congenital

acquired immunodeficiency syndrome, heralded by neurologic invol

acquired immunodeficiency syndrome, infants and children

acquired immunodeficiency syndrome-related complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adrenoleukodystrophy

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

amyloid angiopathy, cerebral

amyloidosis

ANA

anergy

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiotensin-converting enzyme

anti DNA agent

anti JC virus antibodies

antibiotics

anticonvulsants, untoward effects of

arteriovenous malformation

arteriovenous malformation, cerebral

atlanto-axial subluxation

basal ganglia, lesion of

basal ganglia, lesion, bilateral

bone marrow transplantation

brachial neuritis

brachial neuritis, acute

brachial plexus neuropathy

bradyphrenia

brain biopsy

brain biopsy, complications of

brain biopsy, false negative

brain biopsy, indication

brain biopsy, negative

brain biopsy, stereotaxic

brainstem

brainstem, hemorrhage, primary

brainstem, infarction of

brainstem, lesion of

brentuximab

brucellosis, nervous system involvement with

Brudzinski's sign

busulfan

cachexia

calcification, intracranial

calculations

Canavan's disease

candida albicans

carbon monoxide poisoning

carcinoma

cardiac transplantation

carphology

CAT scan

CAT scan, abnormal

CAT scan, contrast enhanced

CAT scan, contrast enhanced, delayed

CAT scan, demyelinating disease

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, mass effect on

CAT scan, serial

cause of death

CD4 counts

celiac disease, adult

central nervous system, infection of

central nervous system, infection, cancer patient

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar hemorrhage

cerebellar lesion

cerebellar peduncle

cerebellum

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cell count, normal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, gold sol.curve of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, pressure increased

cerebrovascular accident

cerebrovascular accident, mimics

cerebrovascular accident, misdiagnosis

cerebrovascular accident, secondary prevention

cerebrovascular disease

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

coccidioidomycosis

cognition

coinfection

collagen vascular disease

Collier's sign

common variable immunodeficiency

complications

compression neuropathy

concentric sclerosis

confabulation

confusion

confusional state, acute

congenital infection, viral

controversies in neurology

cop 1

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cortical blindness

cost effectiveness

cranial nerve palsies

cranial nerves

cranial neuropathy

cranial neuropathy, multiple

creatine phosphokinase(CPK)elevated

cryptococcal meningitis

cryptococcoma, cerebral

cryptococcosis

cyclosporine

cytomegalovirus infection

dementia, differential diagnosis of

demyelinating disease

differential diagnosis

diffuse axonal injury

disability rating scale, neurological

disability, neurological

disorientation

disseminated intravascular coagulation(DIC)

DNA probes

drug abuse

drug abuse, neurologic complications of

drug holiday

drug induced neurologic disorders

drug withdrawal

dural rheumatoid nodules

electroencephalogram, abnormalities of

electron microscopy

encephalitis

encephalitis, brainstem

encephalitis, focal

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, metabolic

endocarditis, marantic

epidemiology of neurology

Epstein-Barr virus

escherichia coli

etanercept

evidence-based research

evoked potentials

experimental allergic encephalitis

finger nose finger test

fingolimod

fluorescent treponema antibody absorption/false positive

frontal lobe, behavior with disease of

fundus, abnormality of

fungal infection, CNS

gadolinium

gait disorder

gammaglobulin therapy, intravenous

gaze palsy

gaze palsy, horizontal

gaze palsy, vertical

genetic neurologic disorders

genu of corpus callosum

glioblastoma multiforme(astrocytoma Gr.III)

gliomatosis cerebri

gram negative rod

granule cell

granulomatous disease

gray matter

Guillain Barre syndrome

gumma

hallucination

hallucination, visual

hemianopia, homonymous

hemiparesis

hemiplegia

hemiplegia, progressive

hepatomegaly

hepatosplenomegaly

heralding manifestation

herpes simplex encephalitis

herpes simplex virus

herpes virus infection

herpes zoster

highly active antiretroviral therapy

human immunodeficiency virus type 1

human immunodeficiency virus type 1, pathogenesis

human immunodeficiency virus type 1, testing

hypertensive encephalopathy

hypoglycorrhachia

hypothalamus

hypothalamus, disturbance of

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic CD4+lymphopenia

imbalance

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune reconstitution inflammatory syndrome, paradoxical

immune reconstitution inflammatory syndrome, unmasked

immune-related adverse events

immunocompetent

immunodeficiency

immunofluorescent exam of CSF cells

immunohistochemistry

immunologic disease

immunology and the nervous system

immunomodulation

immunoperoxidase staining

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

in situ polymerase chain reaction

incidence

inclusion bodies

inclusion bodies, intranuclear

incoordination

infection

infliximab

intellectual deterioration

interferon

interferon beta 1-a

interleukin 2

intracerebral hemorrhage

intracerebral hemorrhage, multiple

intracranial hypertension, benign

intravenous drug abuse

iododeoxyuridine

Jakob-Creutzfeldt disease

JC virus

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

Karnofsky performance scale

Kernig's sign

Korsakoff's psychosis

leg weakness, bilateral

lethargy

leukemia

leukemia, neurologic findings assoc.with

leukodystrophy

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

leukoencephalopathy, toxic

leukostasis

levamisole

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoma of CNS

listeria monocytogenes

listeriosis, CNS

liver transplantation

lymphadenopathy, hilar

lymphocytic interstitial pneumonitis

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

lymphopenia

malabsorption syndrome

malformation, vascular, cerebral

Marchiafava-Bignami disease

medication withdrawal

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, cancer patients with

meningitis, carcinomatous

meningitis, chronic

meningitis, CSF cell count-normal

meningitis, CSF findings in

meningitis, escherichia coli

meningitis, fungal

meningitis, leukemic

meningitis, lymphomatous

meningitis, predisposing factors in

meningitis, pseudomonas

meningitis, spinal fluid smear and culture of

meningitis, TB

meningoencephalitis

meningoencephalitis, amoebic

meningoencephalitis, mumps

mental status, abnormal

metachromatic leukodystrophy

microaneurysm, retinal

midbrain

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebellar peduncle, lesion, bilateral

migraine

mimics

misdiagnosis

mitochondrial disease

mitral valve vegetation

monoclonal antibodies

mononeuritis multiplex

mononeuropathy

mononeuropathy multiplex

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, ADC maps

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, high signal foci on

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, negative

MRI, punctate pattern

multiple sclerosis, acute

multiple sclerosis, diagnosis of

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, etiology of

multiple sclerosis, misdiagnosis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-multiple

neoplasm, second primary

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multiple

neurologic disease, tempo

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuronopathy

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

old age, neurology of

Ommaya reservoir

ophthalmoplegia

opportunistic infection

opportunistic infection, CNS

organ transplantation

osmotic demyelination syndrome

parasitic infection, CNS

pathology

pembrolizumab

pericarditis

peripheral nerve, lesion of

pituitary, metastasis to

plasmapheresis

plasmapheresis, complications of

pleocytosis of cerebrospinal fluid

pneumonia

polymerase chain reaction

polymerase chain reaction, false negative

polymerase chain reaction, false positive

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior fossa

posterior fossa, lesion of

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

practice guidelines

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive multifocal leukoencephalopathy, etiology

progressive neurologic disorder

protease inhibitor, HIV-1

proteus mirabilis

pseudomonas aeruginosa

psoriasis

psychiatric problems in neurologic disorders

psychomotor retardation

psychosis

pulmonary infiltrates

quadriparesis

quality of life

radiation therapy, CNS treatment and complications with

radiculitis

regional enteritis

release phenomena

remote effect of cancer on the nervous system

renal failure

renal stones

renal transplantation

rheumatoid arthritis, neurologic complications of

rheumatoid pachymeningitis

risk factors

risk stratification

risk-benefit assessment

shunt procedure, ventricular

shunt procedure, ventricular-complications of

single photon emission computed tomography

single photon emission computed tomography, thallium

skin, lesions in neurologic disorders

skull x-ray

skull x-ray, abnormal

slow virus infection of CNS

spinal cord, compression of

spinal cord, lesion of

splenectomy

splenomegaly

spongy degeneration of brain

status epilepticus

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stroke center

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subcortical U fibers

subcutaneous nodules

subdural hematoma

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

toxoplasmosis, acquired

toxoplasmosis, CNS

toxoplasmosis, prophylaxis

transient ischemic attack

treatment of neurologic disorder

tremor

tremor, rubral

trigeminal neuropathy

tuberculoma of CNS

tuberculosis

tumor necrosis factor inhibitor

upgaze

uveitis

vaccination, neurologic complications with

vaccine

varicella zoster virus

varicella zoster virus, encephalitis

vasculitides

vasculopathy

ventriculitis

vincristine neurotoxicity

viral infection

viral infection, CNS

viral infection, CNS, treatment of

viral infection, reactivation

visual acuity, decreased

weakness, progressive

weight loss

Whipple's disease

white matter disease

white matter disease, subcortical

white matter, dirty-appearing

wide based gait

Wiskott-Aldrich syndrome

workup

Showing articles 50 to 100 of 2105 << Previous Next >>

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

Clinicopath Conf., Progressive Multifocal Leukoencephalopathy
NEJM 362:1431-1437, Case 11-2010, 2010

Incidence of Progressive Multifocal Leukoencephalopathy in Patients without HIV
Neurol 75:326-1332, Amend,K.I.,et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
NEJM 361:1067-1074, Chen,Y.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Reemergence of PML in Natalizumab-Treated Patients--New Cases, Same Concerns
NEJM 361:1041-1043, Major,E., 2009

Determinants of Survival in Progressive Multifocal Leukoencephalopathy
Neurol 73:1551-1558, Marzocchetti,A.,et al, 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

PML-IRIS in Patients with HIV Infection: Clinical Manifestations and Treatment with Steroids
Neurol 72:1458-1464,1454, Tan,K.,et al, 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

JC Viral Infection-Related Cerebellar Degeneration as the First Manifestation of AIDS
Eur Neurol 59:205-207, Shin,H.-W.,et al, 2008

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007

Misdiagnosis of stroke
Expert Rev Neurother 7:989-1001, Nor, A.M.,et al, 2007

Central Nervous System Infections in Heart Transplant Recipients
Arch Neurol 64:1715-1720, van de Beek,D.,et al, 2007

Inflammatory Progressive Multifocal Leukoencephalopathy in Human Immunodeficiency Virus-Negative Patients
Ann Neurol 62:34-39, Huang,D.R.,et al, 2007

Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006

Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006

Characteristics and Antecedents of Progressive Multifocal Leukoencephalopathy in an Insured Population
Neurol 67:884-886, Eng,P.M.,et al, 2006

Immune Reconstitution Inflammatory Syndrome Associated with PML in AIDS: A Treatable Disorder
Neurol 67:1692-1694, Martinez,J.V.,et al, 2006

Seizures and Their Outcome in Progressive Multifocal Leukoencephalopathy
Neurol 66:262-264, Lima,M.A.,et al, 2006

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006

Sustained Recovery of Progressive Multifocal Leukoencephalopathy After Treatment with IL-2
Neurol 65:1510, Kunschner,L. &Scott,T.F., 2005

JC Virus Granule Cell Neuronopathy: A Novel Clinical Syndrome Distinct from Progressive Multifocal Leukoencephalopathy
Ann Neurol 57:576-580, Koralnik,I.J.,et al, 2005

Atypical PML Leading to a Diagnosis of Common Variable Immunodeficiency
Neurol 64:1661, Snyder,M.D.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005

Progressive Multifocal Leukoencephalopathy After Natalizumab Therapy for Crohns Disease
NEJM 353:362-368, Van Assche,G.,et al, 2005

Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005

Fatal Inflammatory AIDS-Associated PML with High CD4 Counts on HAART: A New Clinical Entity?
Neurol 63:2452-2453, Di Giambenedetto,S.,et al, 2004

Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004

Progressive Multifocal Leukoencephalopathy: Analysis of Lesion Development With Diffusion-Weighted MRI
Neuroradiol 45:717-721, Mader,I.,et al, 2003

Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002

Progressive Multifocal Leukoencephalopathy
Neurol 58:1825, Henderson,R.D.,et al, 2002

HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001

Initial and Follow-up MR Imaging Findings in AIDS-Related Progressive Multifocal Leukoencephalopathy Treated with Highly Active Antiretroviral Therapy
AJNR 22:977-984, Thurnher,M.M.,et al, 2001

Progressive Multifocal Leucoencephalopathy: Progress in the AIDS Era
JNNP 69:569-571, Manji,H. & Miller,R.F., 2000

AIDS-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral Therapy
Neurol 55:1194-1200, Ammassari,A.,et al, 2000

Role of Brain Biopsy in the Management of Focal Brain Lesions in HIV-Infected Patients
Neurol 54:993-997, Antinori,A.,et al, 2000

Progressive Multifocal Leukoencephalopathy and Idiopathic CD4+Lymphocytopenia:A Case Report and Review of Reported Cases
Clin Infect Dis 31:E20-22, Haider,S.,et al, 2000

Progressive Multifocal Leukoencephalopathy Presenting with an Isolated Focal Movement Disorder
Movement Disorder 15:1006-1009, Stockhammer,G.,et al, 2000

Showing articles 50 to 100 of 2105 << Previous Next >>